Atlas Trials

A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients

Clinical trial NCT03317223 · COMPLETED

Trial details

NCT number
NCT03317223
Sponsor
HK inno.N Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2017-10-17
Primary completion
2019-01-21
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.